Barriers to intravenous tissue plasminogen activator for acute stroke therapy in women

Arias, 2004, United States life tables, 2002, Nat Vital Stat Rep, 53 Mosca, 2000, Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States, Arch Fam Med, 9, 506, 10.1001/archfami.9.6.506 Thom, 2006, Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 113, e85, 10.1161/CIRCULATIONAHA.105.171600 Wyller, 1997, Are there gender differences in functional outcome after stroke?, Clin Rehabil, 11, 171, 10.1177/026921559701100211 Roquer, 2003, Sex differences in first-ever acute stroke, Stroke, 34, 1581, 10.1161/01.STR.0000078562.82918.F6 Niewada, 2005, Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial, Neuroepidemiology, 24, 123, 10.1159/000082999 Glader, 2003, Sex differences in management and outcome after stroke: A Swedish national perspective, Stroke, 34, 1970, 10.1161/01.STR.0000083534.81284.C5 Holroyd-Leduc, 2000, Sex differences and similarities in the management and outcome of stroke patients, Stroke, 31, 1833, 10.1161/01.STR.31.8.1833 Kapral, 2005, Sex differences in stroke care and outcomes: Results from the Registry of the Canadian Stroke Network, Stroke, 36, 809, 10.1161/01.STR.0000157662.09551.e5 Lofgren, 1998, In-patient rehabilitation after stroke: Outcome and factors associated with improvement, Disabil Rehabil, 20, 55, 10.3109/09638289809166054 Di Carlo, 2003, Sex differences in the clinical presenta tion, resource use, and 3-month outcome of acute stroke in Europe: Data from a multicenter multinational hospital-based registry, Stroke, 34, 1114, 10.1161/01.STR.0000068410.07397.D7 Henon, 1995, Early predictors of death and disability after acute cerebral ischemic event, Stroke, 26, 392, 10.1161/01.STR.26.3.392 Censori, 1993, Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset, Stroke, 24, 532, 10.1161/01.STR.24.4.532 Angeleri, 1993, The influence of depression, social activity, and family stress on functional outcome after stroke, Stroke, 24, 1478, 10.1161/01.STR.24.10.1478 Samuelsson, 2001, Short-term functional outcome of hospitalised first-ever strokes in Finnmark, Norway in 1998 1999. Results from the Finnmark Stroke Register, Int J Circumpolar Health, 60, 235 Jorgensen, 1999, What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study, Stroke, 30, 2008, 10.1161/01.STR.30.10.2008 Di Carlo, 1999, Stroke in the very old: Clinical presentation and determinants of 3-month functional outcome: A European perspective, Stroke, 30, 2313, 10.1161/01.STR.30.11.2313 Ayala, 2002, Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998, Stroke, 33, 1197, 10.1161/01.STR.0000015028.52771.D1 2005 Kent, 2005, Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: A pooled analysis of randomized clinical trials, Stroke, 36, 62, 10.1161/01.STR.0000150515.15576.29 Savitz, 2005, Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plas minogen activator administration for acute stroke, Stroke, 36, 1447, 10.1161/01.STR.0000170647.42126.a8 Kwan, 2004, Improving the efficiency of delivery of thrombolysis for acute stroke: A systematic review, QTM, 97, 273, 10.1093/qjmed/hch054 Johnston, 2001, Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: The influence of ethnicity, Stroke, 32, 1061, 10.1161/01.STR.32.5.1061 Brown, 2004, Emergency department evaluation of ischemic stroke and TIA: The BASIC Project, Neurology, 63, 2250, 10.1212/01.WNL.0000147292.64051.9B Katzan, 2004, Utilization of intravenous tissue plasminogen activator for acute ischemic stroke, Arch Neurol, 61, 346, 10.1001/archneur.61.3.346 Reed, 2001, Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals, Stroke, 32, 1832, 10.1161/01.STR.32.8.1832 Deng, 2006, IV tissue plasmino gen activator use in acute stroke: Experience from a statewide registry, Neurology, 66, 306, 10.1212/01.wnl.0000196478.77152.fc Qureshi, 2005, Thrombolysis for ischemic stroke in the United States: Data from National Hospital Discharge Survey 1999 2001, Neurosurgery, 57, 647, 10.1227/01.NEU.0000175546.62088.D6 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Cote, 1989, The Canadian Neurological Scale: Validation and reliability assessment, Neurology, 39, 638, 10.1212/WNL.39.5.638 Smith, 2005, Gender comparisons of diagnostic evaluation for ischemic stroke patients, Neurology, 65, 855, 10.1212/01.wnl.0000176054.72325.0f 1996, Practice advisory: Thrombolytic therapy for acute ischemic stroke—summary statement. Report of the Quality Standards Subcommittee of the Ameri can Academy of Neurology, Neurology, 47, 835, 10.1212/WNL.47.3.835 Ferris, 2005, American Heart Association and American Stroke Association National Survey of stroke risk awareness among women, Circulation, 111, 1321, 10.1161/01.CIR.0000157745.46344.A1 Reeves, 2002, Knowledge of stroke risk factors and warning signs among Michigan adults, Neurology, 59, 1547, 10.1212/01.WNL.0000031796.52748.A5 Silver, 2003, Advertising strategies to increase public knowledge of the warning signs of stroke, Stroke, 34, 1965, 10.1161/01.STR.0000083175.01126.62 Pancioli, 1998, Public perception of stroke warning signs and knowledge of potential risk factors, JAMA, 279, 1288, 10.1001/jama.279.16.1288 Kothari, 1997, Patients' awareness of stroke signs, symptoms, and risk factors, Stroke, 28, 1871, 10.1161/01.STR.28.10.1871 Greenlund, 2003, Low public recognition of major stroke symptoms, Am J Prev Med, 25, 315, 10.1016/S0749-3797(03)00206-X Sug Yoon, 2001, Knowledge and perception about stroke among an Australian urban population, BMC Public Health, 1, 14, 10.1186/1471-2458-1-14 Cheung, 2001, Hong Kong patients' knowledge of stroke does not influence time-to-hospital presentation, J Clin Neurosci, 8, 311, 10.1054/jocn.2000.0805 Williams, 1997, Stroke patients' knowledge of stroke. Influence on time to presentation, Stroke, 28, 912, 10.1161/01.STR.28.5.912 Schroeder, 2000, Determinants of use of emergency medical services in a population with stroke symptoms: The Second Delay in Accessing Stroke Healthcare (DASH II) Study, Stroke, 31, 2591, 10.1161/01.STR.31.11.2591 Stone, 1993, The incidence of neglect phenomena and related disorders in patients with an acute right or left hemisphere stroke, Age Ageing, 22, 46, 10.1093/ageing/22.1.46 Starkstein, 1992, Anosognosia in patients with cerebrovascular lesions. A study of causative factors, Stroke, 23, 1446, 10.1161/01.STR.23.10.1446 Baier, 2005, Incidence and diagnosis of anosognosia for hemiparesis revisited, J Neurol Neurosurg Psychiatry, 76, 358, 10.1136/jnnp.2004.036731 Williams, 2000, Stroke symptom attribution and time to emergency department arrival: The delay in accessing stroke healthcare study, Acad Emerg Med, 7, 93, 10.1111/j.1553-2712.2000.tb01900.x Labiche, 2002, Sex and acute stroke presentation, Ann Emerg Med, 40, 453, 10.1067/mem.2002.128682 Tentschert, 2005, Headache at stroke onset in 2196 patients with ischemic stroke or transient ischemic attack, Stroke, 36, e1, 10.1161/01.STR.0000151360.03567.2b Morris, 2000, Prehospital and emergency department delays after acute stroke: The Genentech Stroke Presentation Survey, Stroke, 31, 2585, 10.1161/01.STR.31.11.2585 Azzimondi, 1997, Variables associated with hospital arrival time after stroke: Effect of delay on the clinical efficiency of early treatment, Stroke, 28, 537, 10.1161/01.STR.28.3.537 Goldstein, 2001, Delay between stroke onset and emergency department evaluation, Neuroepidemiology, 20, 196, 10.1159/000054787 Lacy, 2001, Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.), Stroke, 32, 63, 10.1161/01.STR.32.1.63 Smith, 1998, Delayed hospital arrival for acute stroke: The Minnesota Stroke Survey, Ann Intern Med, 129, 190, 10.7326/0003-4819-129-3-199808010-00005 Harraf, 2002, A multicentre observational study of presentation and early assessment of acute stroke, BMI, 325, 17, 10.1136/bmj.325.7354.17 Menon, 1998, Critical factors determining access to acute stroke care, Neurology, 51, 427, 10.1212/WNL.51.2.427 Wester, 1999, Factors associated with delayed admission to hos pital and in-hospital delays in acute stroke and TIA: A prospective, multicenter study, Stroke, 30, 40, 10.1161/01.STR.30.1.40 Chang, 2004, Prehospital delay after acute stroke in Kaohsiung, Taiwan, Stroke, 35, 700, 10.1161/01.STR.0000117236.90827.17 Carroll, 2004, Stroke in Devon: Knowledge was good, but action was poor, J Neurol Neurosurg Psychiatry, 75, 567, 10.1136/jnnp.2003.018382 Kothari, 1999, Acute stroke: Delays to presentation and emergency department evaluation, Ann Emerg Med, 33, 3, 10.1016/S0196-0644(99)70431-2 Salisbury, 1998, Delay in presentation of patients with acute stroke to hospital in Oxford, QTM, 91, 635, 10.1093/qjmed/91.9.635 Jorgensen, 1996, Neurology, 47, 383, 10.1212/WNL.47.2.383 Engelstein, 2000, Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria, Am J Emery Med, 18, 257, 10.1016/S0735-6757(00)90116-5 Wojner-Alexandrov, 2005, Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO), Stroke, 36, 1512, 10.1161/01.STR.0000170700.45340.39 Billings-Gagliardi, 2005, Development and validation of the stroke action test, Stroke, 36, 1035, 10.1161/01.STR.0000162716.82295.ac Kain, 2001, Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease, Br J Haematol, 114, 155, 10.1046/j.1365-2141.2001.02916.x Kain, 2003, Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke, J Thromb Haemost, 1, 390, 10.1046/j.1538-7836.2003.00040.x Broderick, 2001, t-PA Stroke Study Group. Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke, Ann Neurol, 49, 736, 10.1002/ana.1058